Features
16 Mar 10
Back in December it was all but a question of time. More or less every pundit was concerned with ‘when’ and not ‘if’ and an increasingly divided nation was finally bracing itself for the very real possibility of comprehensive healthcare reform. The debate had been more or less exhausted and the Republican strategy continued along the lines of obstructionism pure and simple.
Max Golby - PharmiWeb Field Reporter
17 Feb 10
Research and development is the bread and butter of healthcare innovation. For decades the world’s pharmaceutical companies have treasured and protected this simple maxim, pouring billions of dollars into research and development and creating hundreds of groundbreaking new drugs in the process. Yet since the onset of the global financial crisis in 2007, big pharma has begun to ask some very difficult questions of its research commitments.
Max Golby
.jpg){kind=tracking}
12 Feb 10
Assessing the use of Point Of Care Testing in Clinical Trials - the policies and procedures involved, the benefits Point Of Care can bring to clinical trials and the advantages over the conventional laboratory approach.
Mike Wickham, Dave McComas and Charlotte Wickham
10 Feb 10
Diabetes mellitus – more commonly known as just diabetes – is a chronic metabolic condition that occurs as a result of either the pancreas’ failure to produce normal insulin levels, or as a result of the body’s inability to make use of the insulin that it does produce.
Max Golby
10 Feb 10
A recent research study, which was undertaken as part of medical research charity, Kidney Research UK’s ABLE programme, investigated the impact of national guidelines for the management of Chronic Kidney Disease (CKD), on referral patterns between South Asian and white European patients with type 2 diabetes mellitus (T2DM).
Kidney Research UK
27 Jan 10
RSS is a much under-estimated and under-used thing. It was originally conceived as an easy way of syndicating website content, hence the name “Really Simple Syndication”, but it now become a standard by which content is made available across the web to other sites or users.
Mike Wood
27 Jan 10
At 16:53 local time on Tuesday, 12 January 2010, the small Caribbean island nation of Haiti was dealt another cruel blow: a massive 7.0-magnitude earthquake struck at the heart of the nation - just over 15 miles west of the capital of Port-au-Prince. With the already traumatic history of this poor yet historic nation in mind, the events of January 12 represented yet another devastating hit to the already fragile foundations of this young nation.
Max Golby
21 Jan 10
Hardly a week goes by without Alzheimer’s being in the news – scientists discovering more about what causes it, developing a greater idea of how we can prevent or treat it, or another step being taken towards a cure.
Jackie Cosh, author of Alzheimer’s – The Essential Guide
14 Jan 10
Washington is famous for its lobbyists. Make no mistake, of all the industries currently making themselves heard on Capitol Hill, the healthcare lobby is one of the largest and the loudest. Indeed, according to the Center for Responsive Politics, the pharmaceutical industry had almost 1700 registered lobbyists in Washington as of late 2009. Unsurprisingly, then, the pharmaceutical industry has a considerable degree of pull on The Hill.
Max Golby
23 Dec 09
This is the second of two articles written by Caroline Lock and Spencer Marsh at Only Medics Recruitment Ltd. In the last edition they looked at Recruitment 2010 and in this article they discuss Career Planning 2010.
Stephen Smith
16 Dec 09
For over 75 years now, numerous Democratic Congressmen – and indeed several Presidents – have tried to pass something remotely resembling meaningful healthcare reform. For 75 years, they have failed. Back in 1993, Bill and Hillary Clinton’s failed ‘HillaryCare’ died with a whimper in the Senate and Mrs. Clinton was denied her chance at a second attempt by Mr. Obama in the Democratic primaries.
Max Golby
10 Dec 09
Weekly Swine Flu Update for the Week Ending December 11th.
Max Golby
08 Dec 09
‘You really need some more experience’. Perhaps the most ubiquitous phrase in modern day recruitment, thousands of graduates are now at the mercy of this one requirement as increasing competition in the job market leads to rising standards. Perhaps twenty, or even ten years ago, an undergraduate degree and a forceful sense of charisma might well have been enough to net you your first role in an industry.
Max Golby
08 Dec 09
Keynes called it an ‘inducement to invest’. In this instance, the most recent financial crisis has called for many of the same approaches used in the 1930s to stimulate the economy and bring industries back to their feet. Today more than ever, we realize that education is one of the most decisive facets of any successful stimulus.
Max Golby
08 Dec 09
At what point does a conflict of interests occur? Last year – and for many years before that – U.S. drugs companies paid out tens of millions of dollars in payments and gifts to physicians and academics. Earlier this year, the Pharmaceutical and Research Manufacturers of America (PhRMA) released a revised, and somewhat toughened, code of practice.
Max Golby
07 Dec 09
Over the past year or so, the system for issuing VISAs and work permits in the UK has changed dramatically. A knowledge of the practical implications of the new system will be vital for anyone hoping to bring their skills to the pharmaceutical industry in this country
Max Golby
02 Dec 09
The phrase Halcyon days is a literary commonplace in the English language English language and culture, signifying ideals of prosperity, bonhomie, joy, liberation, or tranquility. I can testify to experiencing all these sentiments having worked in Clinical R&D for nearing 30 years. I'm not so certain we'll ever return to the same again though.
Ann Maloney BSc FICR
26 Nov 09
I recently surveyed a range of pharmaceutical HR managers and recruiters to find out what they consider to be the worst errors you can make on your CV when applying for a pharma job. The results were quite surprising and funny at times, so I have compiled the following 10 point checklist to help you with your CV.
Mike Wood
19 Nov 09
At the Financial Times Global Pharmaceutical and Biotech Conference this week, the keynote address was given by M. Chris Viehbacher, Chief Executive Officer of Sanofi-aventis.
Paul Hartigan
17 Nov 09
We're having a fascinating day at the Financial Times Global Pharmaceutical and Biotechnology conference on London.
Paul Hartigan
17 Nov 09
The craving for cheap drugs has never been greater. For those patients and policymakers in developing countries, the existence of parallel imports is less a concern than a blessing. Yet for pharmaceutical companies themselves, there is the concern that an increasing trade in parallel imports would severely damage research-intensive activities and ultimately slow down the development of the very same drugs that are being traded in ‘grey’ markets today.
Max Golby
02 Nov 09
Weekly Swine Flu Update for the Week Ending November 1st.
Max Golby
28 Oct 09
A difficult economic climate breeds desperation. This is perhaps one of the most plausible explanations for the apparent behaviour of several unethical recruiters in the marketplace.
Max Golby - PharmiWeb Field Reporter
27 Oct 09
Whatever happened to the days of donning your best suit and tie and going out and looking for a job? Knocking on doors and meeting prospective employers, dazzling them with your wit, intelligence and enthusiasm. Unfortunately that is not possible in today’s society.
Trevor Abbott - PharmiWeb Field Reporter
13 Oct 09
Ever since the H1N1 virus first came onto the world map in April, ‘Where’s the vaccine?’ has been the cardinal question on everybody’s lips. As world governments scrambled to control the outbreak, supranational bodies such as the World Health Organization (WHO) threw themselves at the task of producing weekly updates for a virus which we originally knew very little about.
Max Golby
01 Oct 09
Weekly Swine Flu Update for the Week Ending October 2nd.
Max Golby
30 Sep 09
It is frightening because no one knows what's causing it, said a 28-year old law student who went to the St. Mark's Clinic in Greenwich Village last week complaining of swollen glands, thought to be one early symptom of the disease. Every week a new theory comes out about how you're going to spread it. - The New York Times , August 8th 1982.
Max Golby
28 Sep 09
A meta-analysis of the CRYSTAL and OPUS studies involving 845 patients with metastatic colorectal cancer (mCRC) tumours displaying the wild-type KRAS gene, has revealed first-line treatment with Erbitux (cetuximab) and FOLFOX4 or FOLFIRI chemotherapy significantly extends overall survival.
Olwen Glynn Owen
17 Sep 09
Hardly a day goes by without a new report, today AT Kearney, last week Roland Berger and before them IMS and PWC warning of a gloomy future for pharmaceutical companies and saying that they must change their ways.
Paul Dixey, Managing Partner, BlueLight Partners
16 Sep 09
In the eyes of many graduates, the economic recession has brought a new-found negativity to the job market. Thankfully, the climate is probably less dire than the situation sometimes imagined.
Max Golby
